Annals of Medicine Research and Public Health (ISSN: 2995-5955) | Volume 3, Issue 1 | Research Article | Open Access DOI
AJ Remy*
AJ Remy*, H Bouckira, J Hervet, A Happiette, N Ariza
Mobile Hepatitis Team, Perpignan Hospital, France
Fulltext PDFIntroduction: Mobile hepatitis team (MHT) was created in 2013 and cured almost 1000 HCV patients in 10 years in an outreach and test to cure approach. MHT used HCV POCT, HCV real time viral load by GENEXPERT system, liver fibrosis measure by FIBROSCAN and nurse DAA prescription. The missing link from a “all in one” nurse care was DAA prescription which requires a doctor. Methodology: using a health local protocol, our trained nurses could prescribe DAA to no cirrhotic HCV patients and follow up until sustained virological response. Results: As of December 31th, 2023, 39 out of 89 HCV patients in the Viral Hepatitis Expert Service benefited from this protocol, or 44%. Detailed results were detailed on Table 2. Twelve patients were in a situation of recontamination by drug use (31%), 75% in the same living area. Treatment compliance was 95% for the group of patients treated with IDE versus 90% for patients treated by the hepatologist. The main differences between the two groups were less men, younger age, reinfection status, more patients starting treatment at day of DAA prescription and no death in nurse prescription group.
Conclusion: Our results support the hypothesis that an all care nurse model of care is equivalent to hepatologist management of HCV infection. It is a simple and effective tool that frees up physician time, enhances nursing work. There are no disadvantages highlighted after one year of operation. After validation by the national high authority of health, this protocol can be applied to other teams in France.
Direct acting antiviral agents; HCV; Nurse
AJ Remy, H Bouckira, J Hervet, A Happiette, N Ariza. A Nurse Model of All Inclusive Care in The Era of Direct Acting Antiviral Therapy for Hepatitis C Virus Infection: One Year First French Experience. Ann Med Res Pub Health. 2024;3(1):1-8.